MEDICLIN Aktiengesellschaft Cash Flow Reinvestment Rate
MEDICLIN Aktiengesellschaft cash flow reinvestment rate. MEDICLIN Aktiengesellschaft (MED) has a Cash Flow Reinvestment Rate of 0.53x as of December 2025, reinvesting €12.76 Million (capex €12.76 Million ) from operating cash flow of €24.23 Million. See MEDICLIN Aktiengesellschaft leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of MEDICLIN Aktiengesellschaft (2003–2025)
Cash flow reinvestment rate of MEDICLIN Aktiengesellschaft from 2003 to 2025. Historical reinvestment intensity for MEDICLIN Aktiengesellschaft across 23 annual periods. Explore MEDICLIN Aktiengesellschaft cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
MEDICLIN Aktiengesellschaft Cash Flow Reinvestment Rate by Year (2003–2025)
MEDICLIN Aktiengesellschaft cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for MEDICLIN Aktiengesellschaft. For the full cash flow conversion analysis, see MEDICLIN Aktiengesellschaft operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.48x | €48.43 Million | €99.87 Million | €48.43 Million | ▼ -34.7% |
| 2024 | 0.74x | €59.82 Million | €80.57 Million | €44.69 Million | ▲ +49.3% |
| 2023 | 0.50x | €38.79 Million | €78.00 Million | €37.58 Million | ▼ -46.6% |
| 2022 | 0.93x | €32.26 Million | €34.64 Million | €26.02 Million | ▲ +216.8% |
| 2021 | 0.29x | €24.10 Million | €81.97 Million | €17.01 Million | ▲ +35.3% |
| 2020 | 0.22x | €25.79 Million | €118.69 Million | €25.78 Million | ▼ -66.4% |
| 2019 | 0.65x | €44.97 Million | €69.59 Million | €44.93 Million | ▼ -58.7% |
| 2018 | 1.57x | €46.47 Million | €29.68 Million | €46.42 Million | ▼ -15.3% |
| 2017 | 1.85x | €35.74 Million | €19.34 Million | €35.72 Million | ▲ +25.4% |
| 2016 | 1.47x | €44.06 Million | €29.90 Million | €26.15 Million | ▲ +64.2% |
| 2015 | 0.90x | €25.96 Million | €28.92 Million | €25.92 Million | ▲ +44.1% |
| 2014 | 0.62x | €20.01 Million | €32.13 Million | €19.98 Million | ▼ -62.8% |
| 2013 | 1.68x | €16.68 Million | €9.95 Million | €16.63 Million | ▲ +9.5% |
| 2012 | 1.53x | €24.75 Million | €16.17 Million | €24.75 Million | ▼ -13.1% |
| 2011 | 1.76x | €27.52 Million | €15.63 Million | €27.52 Million | ▲ +10.4% |
| 2010 | 1.60x | €21.32 Million | €13.37 Million | €21.32 Million | ▲ +170.4% |
| 2009 | 0.59x | €19.08 Million | €32.35 Million | €19.08 Million | ▼ -68.1% |
| 2008 | 1.85x | €39.81 Million | €21.53 Million | €39.81 Million | — |
| 2007 | 0.00x | €0.00 | €16.41 Million | €0.00 | — |
| 2006 | 0.00x | €0.00 | €13.39 Million | €0.00 | — |
| 2005 | 0.00x | €0.00 | €17.52 Million | €0.00 | ▼ -100.0% |
| 2004 | 1.73x | €19.05 Million | €11.00 Million | €19.05 Million | ▲ +25.4% |
| 2003 | 1.38x | €10.47 Million | €7.58 Million | €10.47 Million | — |